Auro Laboratories Ltd.

Financial

	Auro Laboratories	Parnax Lab	Tyche Inds
Operational Metrics
Financials
5 yr Average ROE	15.74 %	6.88 %	14.86 %
5yr average Equity Multiplier	1.68	2.94	1.18
5yr Average Asset Turnover Ratio	1.03	0.99	0.6
5yr Avg Net Profit Margin	9.45 %	2.37 %	20.15 %
Price to Book	3.47	1.79	1.08
P/E	213.2	13.8	12.13
5yr Avg Cash Conversion Cycle	34.28 Days	42.8 Days	86.71 Days
Inventory Days	40.18 Days	42.33 Days	61.45 Days
Days Receivable	87.78 Days	58.46 Days	108.17 Days
Days Payable	76.54 Days	69.32 Days	93.08 Days
5yr Average Interest Coverage Ratio	12.13	2.32	2385.83
5yr Avg ROCE	20.0 %	15.17 %	19.65 %
5yr Avg Operating Profit Margin	14.46 %	11.62 %	23.57 %
5 yr average Debt to Equity	0.3	1.28	0.0
5yr CAGR Net Profit	13.98 %	n/a	-6.96 %
5yr Average Return on Assets	9.66 %	2.67 %	12.43 %
Shareholdings
Promoter Holding	52.18 %	72.3 %	61.97 %
Share Pledged by Promoters	0.0	9.41 %	0.0
Change in Promoter Holding (3 Yrs)	0.09 %	4.72 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Auro Laboratories	Parnax Lab	Tyche Inds
Product Wise Break-Up	Product Wise Break-Up Manufacture of bulk drugs intermediates 0 Others 100	Product Wise Break-Up Manufacture of bulk drugs intermediates 0 Others 100	Product Wise Break-Up Bulk Chemicals 100.0